版本:
中国

BRIEF-OncoSec says presents preclinical data demonstrating improved systemic anti-tumor response following modifications to il-12 gene delivery therapy

April 3 OncoSec Medical Inc

* OncoSec Medical says presents preclinical data demonstrating improved systemic anti-tumor response following modifications to IL-12 gene delivery therapy Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐